Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. John M, Constien R, Akinc A, Goldberg M, Moon YA, Spranger M, Hadwiger P, Soutschek J, Vornlocher HP, Manoharan M, Stoffel M, Langer R, Anderson DG, Horton JD, Koteliansky V, Bumcrot D. Nature. 2007 Oct 11;449(7163):745-7. Epub 2007 Sep 26. View Abstract on PubMed
Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel. Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, Müller M, Wacheck V.Anticancer Drugs. 2007 Aug;18(7):755-61. View Abstract on PubMed
Interfering with disease: a progress report on siRNA-based therapeutics. de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Nat Rev Drug Discov. 2007 Jun;6(6):443-53. Review. View Abstract on PubMed